Louis Manzo - Net Worth and Insider Trading
Louis Manzo Net Worth
The estimated net worth of Louis Manzo is at least $1 Million dollars as of 2024-11-13. Louis Manzo is the Director of Capricor Therapeutics Inc and owns about 77,654 shares of Capricor Therapeutics Inc (CAPR) stock worth over $1 Million. Details can be seen in Louis Manzo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Louis Manzo has not made any transactions after 2017-05-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Louis Manzo
Louis Manzo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Louis Manzo owns 1 companies in total, including Capricor Therapeutics Inc (CAPR) .
Click here to see the complete history of Louis Manzo’s form 4 insider trades.
Insider Ownership Summary of Louis Manzo
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CAPR | Capricor Therapeutics Inc | 2019-12-17 | director |
Louis Manzo Latest Holdings Summary
Louis Manzo currently owns a total of 1 stock. Louis Manzo owns 77,654 shares of Capricor Therapeutics Inc (CAPR) as of May 9, 2017, with a value of $1 Million.
Latest Holdings of Louis Manzo
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CAPR | Capricor Therapeutics Inc | 2017-05-09 | 77,654 | 18.10 | 1,405,537 |
Holding Weightings of Louis Manzo
Louis Manzo Form 4 Trading Tracker
According to the SEC Form 4 filings, Louis Manzo has made a total of 0 transactions in Capricor Therapeutics Inc (CAPR) over the past 5 years. The most-recent trade in Capricor Therapeutics Inc is the acquisition of 1,000 shares on May 9, 2017, which cost Louis Manzo around $31,000.
Insider Trading History of Louis Manzo
- 1
Louis Manzo Trading Performance
GuruFocus tracks the stock performance after each of Louis Manzo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Louis Manzo is 14.49%. GuruFocus also compares Louis Manzo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Louis Manzo within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Louis Manzo's insider trading performs compared to the benchmark.
Performance of Louis Manzo
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -23.33 | | | | | |
| Relative Return to S&P 500(%) | -25.37 | | | | | |
Louis Manzo Ownership Network
Ownership Network List of Louis Manzo
Ownership Network Relation of Louis Manzo
Louis Manzo Owned Company Details
What does Capricor Therapeutics Inc do?
Who are the key executives at Capricor Therapeutics Inc?
Louis Manzo is the director of Capricor Therapeutics Inc. Other key executives at Capricor Therapeutics Inc include CHIEF BUSINESS OFFICER Xavier Avat , director & CHIEF EXECUTIVE OFFICER Linda Marban , and EVP & GENERAL COUNSEL Karen Krasney .
Capricor Therapeutics Inc (CAPR) Insider Trades Summary
Over the past 18 months, Louis Manzo made no insider transaction in Capricor Therapeutics Inc (CAPR). Other recent insider transactions involving Capricor Therapeutics Inc (CAPR) include a net purchase of 7,993 shares made by David B Musket , a net purchase of 2,798,507 shares made by , and a net purchase of 10,000 shares made by Collier Earl M Jr .
In summary, during the past 3 months, insiders sold 0 shares of Capricor Therapeutics Inc (CAPR) in total and bought 2,798,507 shares, with a net purchase of 2,798,507 shares. During the past 18 months, 0 shares of Capricor Therapeutics Inc (CAPR) were sold and 2,821,500 shares were bought by its insiders, resulting in a net purchase of 2,821,500 shares.
Capricor Therapeutics Inc (CAPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Capricor Therapeutics Inc Insider Transactions
Louis Manzo Mailing Address
Above is the net worth, insider trading, and ownership report for Louis Manzo. You might contact Louis Manzo via mailing address: C/o Capricor Therapeutics, Inc., 8840 Wilshire Blvd., 2nd Floor, Beverly Hills Ca 90211.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
